ACUSENSUS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.615 AUD | +2.50% |
|
-2.38% | -22.15% |
| 04-18 | Acusensus Files Infringement Proceedings Against One Task | MT |
| 02-26 | Acusensus Narrows Loss in Fiscal H1 Despite 25% Rise in Revenue; Shares Jump 4% | MT |
Valuation
| Fiscal Period: June | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 77.74 | - | - |
| Enterprise Value (EV) 1 | 56.24 | 59.34 | 61.94 |
| P/E ratio | - | 308 x | 103 x |
| Yield | - | - | - |
| Capitalization / Revenue | 1.54 x | 1.32 x | 1.15 x |
| EV / Revenue | 1.12 x | 1 x | 0.92 x |
| EV / EBITDA | 13.7 x | 12.9 x | 12.1 x |
| EV / FCF | -17 x | -19.1 x | -23.8 x |
| FCF Yield | -5.87% | -5.22% | -4.2% |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 126,411 | - | - |
| Reference price 2 | 0.6150 | 0.6150 | 0.6150 |
| Announcement Date | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | 28.73 | 50.4 | 59.1 | 67.5 |
| EBITDA 1 | - | 4.1 | 4.6 | 5.1 |
| EBIT 1 | - | -0.3 | 0.3 | 0.8 |
| Operating Margin | - | -0.6% | 0.51% | 1.19% |
| Earnings before Tax (EBT) | - | - | 0.3 | 0.8 |
| Net income 1 | 1.426 | 0.1 | 0.3 | 0.8 |
| Net margin | 4.96% | 0.2% | 0.51% | 1.19% |
| EPS | - | - | 0.002000 | 0.006000 |
| Free Cash Flow 1 | - | -3.3 | -3.1 | -2.6 |
| FCF margin | - | -6.55% | -5.25% | -3.85% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 10/01/23 | - | - | - |
1AUD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 21.5 | 18.4 | 15.8 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | - | -3.3 | -3.1 | -2.6 |
| ROE (net income / shareholders' equity) | - | -0.8% | 0.7% | 2.1% |
| ROA (Net income/ Total Assets) | - | -0.6% | 0.5% | 1.4% |
| Assets 1 | - | -16.67 | 60 | 57.14 |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | 5 | 5 | 5 |
| Capex / Sales | - | 9.92% | 8.46% | 7.41% |
| Announcement Date | 10/01/23 | - | - | - |
1AUD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.615
AUD
Average target price
1.3
AUD
Spread / Average Target
+111.38%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.15% | 51.62M | |
| -7.96% | 187B | |
| +26.39% | 93.27B | |
| +51.52% | 62.84B | |
| +16.55% | 60.86B | |
| +27.47% | 31.47B | |
| +17.66% | 21.49B | |
| +2.33% | 20.45B | |
| +39.29% | 17.14B | |
| +1.81% | 16.55B |
- Stock Market
- Equities
- ACE Stock
- Financials Acusensus Limited
